Benzodiazepine Use and Misuse Among Adults in the United States
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Goals were to determine the prevalence of benzodiazepine use (as prescribed and misuse), characterize misuse, and examine variation by age. METHODS: A cross-sectional analysis was conducted of 2015 and 2016 National Survey on Drug Use and Health data limited to adults ≥18 (N=86,186) and data from those respondents reporting benzodiazepine use (N=10,290). Measurements included past-year prescription benzodiazepine use and misuse ("any way a doctor did not direct"), substance use disorders, mental illness, and demographic characteristics. Misuse was compared between younger (18-49) and older (≥50) adults. RESULTS: A total of 30.6 million adults (12.6%) reported past-year benzodiazepine use-25.3 million (10.4%) as prescribed and 5.3 million (2.2%) misuse. Misuse accounted for 17.2% of overall use. Adults ages 50-64 had the highest prescribed use (12.9%). Those ages 18-25 had the highest misuse (5.2%), and those ages ≥65 had the lowest (.6%). Misuse and abuse of or dependence on prescription opioids or stimulants were strongly associated with benzodiazepine misuse. Benzodiazepine misuse without a prescription was the most common type of misuse, and a friend or relative was the most common source. Adults ages ≥50 were more likely than younger adults to use a benzodiazepine more often than prescribed and to use a benzodiazepine to help with sleep. CONCLUSIONS: Benzodiazepine use among U.S. adults was higher than previously reported, and misuse accounted for nearly 20% of use overall. Use by adults ages 50-64 now exceeds use by those ages ≥65. Patients also prescribed stimulants or opioids should be monitored for benzodiazepine misuse. Improved access to behavioral interventions for sleep or anxiety may reduce some misuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Since benzodiazepines are among the most frequently prescribed drugs in the United States, treatments for BIND represent an urgent unmet medical need [25].”
From Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey (2023) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundMeta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
Woolcott, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.357 · Cited by 1,326 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundExplicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update
Beers, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440350031003 · Cited by 1,059 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · cited 1×
“A significant proportion of the NSDUH-defined “misuse”, therefore, could reflect use for untreated symptoms among those with poor access to care—specifically behavioral treatments for insomnia (31, 32) or anxiety disorders (33, 34).”
BackgroundPark, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Help-seeking behaviour in men and women with common mental health problems: cross-sectional study
Oliver, M. I., Pearson, N., Coe, N., & Gunnell, D. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.4.297 · Cited by 558 · cited 1×
“This may further support the hypothesis that higher misuse is partially a function of limited access to a prescribed option—limited for younger patients due to lack of insurance and for men due to minimal disclosure of mental health concerns to providers (42).”
BackgroundBenzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548 · cited 1×
“While use among those ≥65 has not been declining (1, 3), the decades of evidence regarding safety concerns (4, 7, 27) and professional guidelines (6, 28) recommending limited use in older adults may have helped slow growth.”
Background
Research works printed but not linked: 2
- Lipari RN, Williams M, Van Horn SL. Why Do Adults Misuse Prescription Drugs? 2017 7 27 In: The Center for Behavioral Health Statistics and Quality Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US) Available from: https://www.ncbi.nlm.nih.gov/books/NBK458284/ 28968046
- Center for Behavioral Health Statistics and Quality. (2016). 2015 National Survey on Drug Use and Health: Summary of the Effects of the 2015 NSDUH Questionnaire Redesign: Implications for Data Users. Substance Abuse and Mental Health Services Administration, Rockville, MD. 30199192
Cited by
Items 301–351 of 351
ADHD and the Risk of Benzodiazepine Misuse: A Systematic Review and Meta-Analysis
Zamboni, L., Federico, A., Casari, R., Fusina, F., Zandonai, T., Zoccante, L., & Lugoboni, F. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2576652
“Among the substances commonly mis-used, benzodiazepines (BDZs) are of particular concern due to their widespread prescription for anxiety and insomnia, coupled with their high potential for dependence and misuse (Maust et al., 2019; Olfson et al., 2015; Wilens et al., 2003).”
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Figshare · doi:10.6084/m9.figshare.20279386
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Figshare · doi:10.6084/m9.figshare.20279395
Niznik, J., Ferreri, S. P., Armistead, L. T., Urick, B. Y., Vest, M.-H., Zhao, L., Hughes, T. D., McBride, J. M., & Busby‐Whitehead, J. (2022) · Figshare · doi:10.6084/m9.figshare.19518102
Maust, D. T., Bohnert, A. S. B., Strominger, J., Alexander, N., Min, L. C., Hoffman, G. J., & Goldstick, J. E. (2022) · Figshare · doi:10.6084/m9.figshare.21406992
Self-citationEvrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Figshare · doi:10.6084/m9.figshare.20279392
Maust, D. T., Bohnert, A. S. B., Strominger, J., & Goldstick, J. E. (2024) · Figshare · doi:10.6084/m9.figshare.26590611
Self-citationEvrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Figshare · doi:10.6084/m9.figshare.20279383
Educating Providers on Effective Prescribing of Benzodiazepine
NWAKAMMA, J. (2024) · ScholarWorks (Walden University)
The Relationship Between Postoperative Prescriber Networks and Opioid Prescribing Discoordination
Nilsen, E. A. (2024) · D-Scholarship@Pitt (University of Pittsburgh)
Baudot, F.-O. (2022) · theses.fr (ABES)
Peer Recovery Support Effects on Substance Abuse in Rural Outpatient Community Behavioral Health
Bruce, M. (2024) · ScholarWorks (Walden University)
Bradford, A. C. (2025) · The Conversation · doi:10.64628/aai.g37rwskch
Benzodiazepine use and the effect on worker health
Bass, L. A. (2025) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.008148
Exploration of Extended-Release Lorazepam: Implications for Safe Nurse Practitioner Practice
Kverno, K. S., & Biernacki, P. J. (2025) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20251208-02
de Brea, L. M. T., Pedrosa, S., & Sanjur, S. (2025) · Centros · doi:10.48204/j.centros.v15n1.a6951
McGraw, C., Crawley, W. T., Zaw-mon, C., Palacio, C. H., Sliter, R. J., Banton, K. L., & Bar‐Or, D. (2026) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2025-002036
“9 27 While prior research has focused largely on younger trauma patients with major injuries, there is limited understanding of how benzodiazepine-related polysubstance use affects hospital resource utilization in older adults.”
The risk of suicidal behavior associated with prescription benzodiazepine treatment initiation
Chirica, M. G., Rickert, M. E., Meraz, R., Adams, S. M., Kroenke, K., Chang, Z., Quinn, P. D., & D'Onofrio, B. M. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117033
Hamadieh, Z., Goldfarb, D. G., & Ellendon, N. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07931-3
“In comparison, approximately 17.2% of adults who use BZDs engaged in misuse in the United States [3].”
InfluentialGao, S., Feng, X., Li, Q., & Fan, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1788736
Comprehensive examination of the patterns, correlates, and motivations for benzodiazepine use
Péter, L. (2025) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12671
Safety of Anxiolytics: Analyzing the Russian Database of Spontaneous Reports
Gomon, Y. М., Анатольевна, Л. В., Колбин, А. С., Горелов, К. В., & Незнанов, Н. Г. (2026) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2026-540
Benzodiazepine use : a two-way relationship with work accidents and impact of COVID-19 pandemic
Baudot, F.-O. (2022) · theses.fr (ABES) · doi:10.70675/88942d7fzaddbz4b8cz91b9zcc0b92de1598
Galdieri, D. A., Nolder, K. A., Mahoney, C., & Anderson, K. G. (2026) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2026.174198
Hanoa, K., & Gjersing, L. (2026) · Journal of Substance Use · doi:10.1080/14659891.2026.2658808
Reed, G. E., McMahan, V., Chang, Y.-S. G., Johnson, N. L., Walley, A. Y., Coffin, P. O., & Harris, M. T. H. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01451-9
“However, existing literature indicates differences in co-use rates among Black and Latino individuals for alcohol versus benzodiazepines [7, 8, 19].”
Rhinitis medicamentosa: Still searching for “new” behavioural addictions?
Starčević, V., & Schimmenti, A. (2026) · Journal of Behavioral Addictions · doi:10.1556/2006.2025.00359
Chapter 1. Introduction to Substance Use Among Older Adults
Bessey, L. J., Oseni, D., & Walaszek, A. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551968.lg01
Sharma, N., Rana, R., & Kar, N. (2026) · Archives of Mental Health · doi:10.4103/amh.amh_119_25
Teneurin C-terminal associated peptide-1 attenuates chronic stress in male rats
Mueller, L. E., Siemian, J. N., Lovejoy, D. A., Stein, R. B., & Slee, A. (2026) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000886
“…symptoms rather than underlying mechanisms, the potential for development of dependence for benzodiazepines, and their failure to provide adequate relief for the vast majority of patients (Edwards and Anderson, 1999; Maust et al ., 2019; Chiappini et al ., 2022; Bounds, 2025; The Lancet, 2025).”
Chun, H.-R., Lee, N.-R., Yim, H. W., Jeong, H., Cheon, Y.-H., Lee, S., & Lee, H. K. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e261
“26,27 Across all groups, participants commonly exhibited poor mental health, as indicated by higher levels of depression, anxiety, or ASI psychiatric severity.”
Benzodiazepine Prescriptions to Older Adults in the United States, 2015 to 2024
Olfson, M., Xie, F., Bushnell, G., Cruz, N., Hua, J., Miles, J., & Crystal, S. (2026) · Annals of Internal Medicine · doi:10.7326/annals-25-05594
Wang, F., Meng, L., Bogar, K. F., Brensinger, C. M., Bilker, W. B., Dublin, S., Hecht, T. E. H., Horn, J. R., Moga, D. C., Thase, M. E., et al. (2026) · Clinical Drug Investigation · doi:10.1007/s40261-026-01582-8
“According to a survey by the Substance Abuse and Mental Health Services Administration, >30 million American adults reported using BZDs in the past year [6].”
Hartung, D. M., Servid, S. A., Middleton, L., Klein, T., Geddes, J., Anderson, T. S., & Park, T. W. (2026) · Medical Care · doi:10.1097/mlr.0000000000002360
Rahman, N. F., & Agus, W. (2026) · Journal Of Tropical Pharmacy And Chemistry · doi:10.30872/jtpc.v10i2.402
“These limitations underscore the urgent need for safer and more effective therapeutic alternatives, particularly those derived from natural products with lower toxicity profiles [1], [6], [7].”
Liang, R., Zhang, X., Li, H., Li, Z., Hu, Y., Ma, L., Liang, Z., & Liu, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1827554
Song, Z., Li, N., Song, R., Zheng, C., Wang, C., Liao, F., Yuan, D., Long, Y., Hong, H., Chen, Z., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179212
Sosialisasi Kegiatan Webinar: Kenali Bahaya Penyalahgunaan Obat Sedatif Sejak Dini
Widjaja, H., Aryanilo, A., Haryana, A. A., Pramesti, J., Hutapea, M. P., Tandang, S. J. L., Khaerunisa, P., Dellafanny, R., Soares, F. M. A. D. J., & Novaliani, W. (2026) · Nuras Jurnal Pengabdian Kepada Masyarakat · doi:10.36312/nuras.v6i3.1242
Bipolar Disorder and Addiction
Lim, E., & Sohn, I. (2026) · Springer eBooks · doi:10.1007/978-981-92-1323-8_11
Emotional Neglect in Childhood and Benzodiazepine Misuse in Rhode Island Young Adults
Bradford, C., & Rosenthal, S. R. (2026) · Addiction & Prevention · doi:10.3390/addictprev1010006
“Benzodiazepine misuse is most prevalent among young adults aged 18–25, with 5.2% reporting lifetime misuse as of 2018 [1].”
InfluentialKalia, V., Rajendrakumar, A. L., Cruz-Nieto, R., Ramírez, A., González-Ruíz, J., Nandakumar, R., Udhani, H. H., McNeil, B., Xie, C., Dubey, S., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.125601
Toohey, C. (2025) · Otago University Research Archive (University of Otago)
Radukic, T., Martinović, J., Dragić, M., Zeljković, M., Popovic, D., Jasnic, N. I., Stekić, A., & Kontić, M. Z. (2026) · Pharmaceuticals · doi:10.3390/ph19091433
“However, BZDs are also among the most frequently misused prescription drugs and carry a substantial risk of abuse, tolerance, physical dependence, and development of withdrawal symptoms after dose reduction or treatment discontinuation [1–4].”
Victor, A., Romain, O., Brière, O., Gautier, J., Spiesser-Robelet, L., Annweiler, C., & Corvaisier, M. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106413
Carrazana, E. J., Sirven, J. I., Stern, J. M., Gidal, B. E., Kanner, A. M., & Rabinowicz, A. L. (2026) · Neurology and Therapy · doi:10.1007/s40120-026-01007-w
Benzodiazepines use in primary care England: Prescribing patterns and adverse consequences
Chaudhry, A., Khan, M. U., Conway, B. R., & Hasan, S. S. (2026) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70824 · Cited by 1
Hall, P., Beaman, J., Naberhaus, B., & Do, C. (2024) · Oklahoma State Medical Proceedings
Incident Sedative Use Disorder After Benzodiazepine Treatment in Adolescents and Emerging Adults
Bushnell, G., Keyes, K. M., McCabe, S. E., Cerdá, M., Gerhard, T., Hasin, D. S., 苟卓越, & Olfson, M. (2026) · JAACAP Open · doi:10.1016/j.jaacop.2026.10.004
Managing coexisting depression and substance use disorder: insights from clinical experience
Schifano, F., Martinotti, G., Wojnar, M., de Melo, I. H., Korbel, C., & Sani, G. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1919720
“Benzodiazepines are most frequently prescribed to females aged 50 – 64 years for insomnia and/or anxiety, although misuse may occur more commonly in younger adults (28).”
Alharbi, Y. A., Alghamdi, Y. I., Alshaikh, J. H., Alawaji, D. A., Baamer, R. M., Ajabnoor, A. M., Alqahtani, Z. A., Alsuhibani, A. A., & Almadfaa, R. O. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2757900
Metadata
- Authors
- Maust, D. T., Lin, L. A., & Blow, F. C.
- Affiliations
- University of Michigan (US)
- Venue
- Psychiatric Services
- Published
- 2019-02-01
- Volume
- 70
- Issue
- 2
- Pages
- 97-106
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- PMC
- PMC6358464
- OpenAlex
- W2904755589
- Cited by
- 337
- References
- 42
- Citations by year
- 2026: 40 · 2025: 50 · 2024: 72 · 2023: 48 · 2022: 56 · 2021: 27 · 2020: 35 · 2019: 8
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA045705)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- benzodiazepine misuse, benzodiazepine use, prescription drug misuse, prevalence, age differences, substance use disorders, opioid misuse, stimulant abuse, sleep aids, benzodiazepine dependence, National Survey on Drug Use and Health
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Benzodiazepines, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Drug Prescriptions, United States, Prevalence, Young Adult, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.